U.S. market Closed. Opens in 11 hours 16 minutes

CLB | Core Laboratories N.V. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for CLB we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very strong.

Valuation (62%)

Company Industry
P/E Ratio (TTM) 28.51 14.34
PEG Ratio (TTM) 0.32 4.45
P/S Ratio (TTM) 1.55 1.49
P/B Ratio (TTM) 3.32 2.67
P/FCF Ratio (TTM) 26.92 12.46
Price to 5YR AVG Earnings Ratio 48.55 -2.29
Price to 5YR AVG FCF Ratio 24.13 48.79

Profitability (30%)

Company Industry
ROA (TTM) 4.68% 8.33%
ROE (TTM) 12.14% 20.04%
Net Profit Margin (TTM) 5.44% 11.00%
ROIC 5YR AVG 9.11% 6.11%

Growth (27%)

4QTR AVG 3YR AVG 5YR AVG
EPS 9.11% -32.52% -39.51%
Revenue 0.54% -8.81% -25.29%
Net Income 10.16% -25.42% -35.25%
Cash Flow 2,263.81% -30.70% -24.91%

Health (77%)

Company Industry
Current Ratio (TTM) 2.39 1.82
Quick Ratio (TTM) 1.68 1.31
D/E Ratio (TTM) 0.66 0.76
Interest Coverage (TTM) 3.95 12.05
Piotroski F-Score 6 7
Altman Z-Score 3.09 2.87
LTL to 5YR AVG FCF 4.94 9.77
Shares Outstanding Growth 5YR AVG 1.04% 7.00%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙